Cargando…

Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis

IMPORTANCE: Pre-exposure prophylaxis with neutralizing SARS-CoV-2 monoclonal antibodies (mAbs PrEP) prevents infection and reduces hospitalizations and the duration thereof for COVID-19 and death among high-risk individuals. However, reduced effectiveness due to a changing SARS-CoV-2 viral landscape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popping, Stephanie, Nichols, Brooke E., Appelman, Brent, Biemond, Jason J., Vergouwe, Magda, Rosendaal, Frits R., van der Valk, Marc, de Bree, Godelieve J., Wiersinga, W. Joost, Birnie, Emma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326646/ https://www.ncbi.nlm.nih.gov/pubmed/37410460 http://dx.doi.org/10.1001/jamanetworkopen.2023.21985

Ejemplares similares

Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change
por: Birnie, Emma, et al.
Publicado: (2022)

Association of clinical sub-phenotypes and clinical deterioration in COVID-19: further cluster analyses
por: Schinkel, Michiel, et al.
Publicado: (2021)

Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort
por: Appelman, Brent, et al.
Publicado: (2022)

Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US
por: Flaxman, Abraham D., et al.
Publicado: (2022)

Association of Remote History of Venous Thrombosis With Risk of Venous Thrombosis After Age 70 Years
por: Wang, Huijie, et al.
Publicado: (2022)

Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins
por: Rivera, Adovich S., et al.
Publicado: (2023)

Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
por: Vita, Serena, et al.
Publicado: (2022)

A Graphical Overview of the Histopathology of Human Melioidosis: A Case Series
por: Savelkoel, Jelmer, et al.
Publicado: (2023)

Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States
por: McManus, Kathleen A., et al.
Publicado: (2020)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Appropriateness of Surgical Antimicrobial Prophylaxis Practices in Australia
por: Ierano, Courtney, et al.
Publicado: (2019)

Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands
por: Bedene, Ajda, et al.
Publicado: (2019)

Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19
por: Slim, Marleen A., et al.
Publicado: (2021)

Engineering monoclonal antibodies for COVID-19 prophylaxis
por: Izadpanah, Amin, et al.
Publicado: (2022)

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial
por: Abella, Benjamin S., et al.
Publicado: (2020)

Human monoclonal antibodies for prophylaxis and therapy of viral infections
por: Meulen, Jan ter, et al.
Publicado: (2006)

Risk of Rabies and Implications for Postexposure Prophylaxis Administration in the US
por: Charniga, Kelly, et al.
Publicado: (2023)

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
por: ter Meulen, Jan, et al.
Publicado: (2004)

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
por: Huang, Yunda, et al.
Publicado: (2023)

Assessment of Guideline Discordance With Antimicrobial Prophylaxis Best Practices for Common Urologic Procedures
por: Khaw, Chelsea, et al.
Publicado: (2018)

Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2
por: Eder, Julia, et al.
Publicado: (2022)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Statins and Venous Thrombosis: A Story Too Good to Be True?
por: Rosendaal, Frits R.
Publicado: (2012)

Bridging case-control studies and randomized trials
por: Rosendaal, Frits R
Publicado: (2001)

Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
por: Rosendaal, Frits R.
Publicado: (2020)

Genomic Correlates of Virulence Attenuation in the Deadly Amphibian Chytrid Fungus, Batrachochytrium dendrobatidis
por: Refsnider, Jeanine M., et al.
Publicado: (2015)

A simple method to adjust clinical prediction models to local circumstances
por: Janssen, Kristel J. M., et al.
Publicado: (2009)

Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US
por: Harrington, Kristin R. V., et al.
Publicado: (2023)

Inflammation-Induced Alternative Pre-mRNA Splicing in Mouse Alveolar Macrophages
por: Janssen, William J., et al.
Publicado: (2019)

Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015
por: Suda, Katie J., et al.
Publicado: (2019)

A Collection of Pre-mRNA Splicing Mutants in Arabidopsis thaliana
por: Kanno, Tatsuo, et al.
Publicado: (2020)

The Development of a Monoclonal Antibody Recognizing the Drosophila melanogaster Phosphorylated Histone H2A Variant (γ-H2AV)
por: Lake, Cathleen M., et al.
Publicado: (2013)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes
por: Ambrose, Nalini, et al.
Publicado: (2023)

Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
por: De Benedictis, Paola, et al.
Publicado: (2016)

Antibiotic prophylaxis in breast cancer surgery. A randomized controlled trial
por: Prudencio, Rubens Murilo de Athayde, et al.
Publicado: (2020)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_002san8hpj824grl5svtkfg7g1